Joel Gozlan

Summary

Country: France

Publications

  1. pmc Stepwise release of biologically active HMGB1 during HSV-2 infection
    Chloé Borde
    Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie, Universite Paris Descartes, INSERM, UMRS872, Paris, France
    PLoS ONE 6:e16145. 2011
  2. doi request reprint Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV
    Joel Gozlan
    Service de Bacteriologie Virologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France
    J Hepatol 50:432-4. 2009
  3. pmc Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients
    Karine Lacombe
    INSERM UMR S707, Paris, France
    Antivir Ther 13:705-13. 2008
  4. doi request reprint High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients
    Karine Lacombe
    INSERM UMR S707, Paris, France
    Hepatology 58:912-22. 2013
  5. ncbi request reprint Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV
    Karine Lacombe
    INSERM U707, Paris, France
    AIDS 20:419-27. 2006
  6. doi request reprint Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients
    Sarah Maylin
    Laboratoire de Virologie, Hopital Saint Louis, AP HP, Paris, France
    AIDS 26:939-49. 2012
  7. pmc Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region
    Julie Bottero
    INSERM UMR S707, Paris, France Université Pierre et Marie Curie, Paris, France Service de Maladies Infectieuses, Hopital St Antoine, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    PLoS ONE 9:e92266. 2014
  8. doi request reprint Drug-resistant and immune-escape HBV mutants in HIV-infected hosts
    Karine Lacombe
    INSERM, UMR S707, Paris, France
    Antivir Ther 15:493-7. 2010
  9. pmc A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes
    Claire Gaillard
    Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie, Universite Paris Descartes, INSERM, Paris, France
    PLoS ONE 3:e2855. 2008
  10. doi request reprint Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells
    Nadine Nasreddine
    INSERM Unité 743, Centre de Recherche des Cordeliers, Paris F 75006, France
    J Immunol 186:5687-95. 2011

Collaborators

Detail Information

Publications20

  1. pmc Stepwise release of biologically active HMGB1 during HSV-2 infection
    Chloé Borde
    Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie, Universite Paris Descartes, INSERM, UMRS872, Paris, France
    PLoS ONE 6:e16145. 2011
    ..We therefore investigated the dynamics and biological effects of HMGB1 during HSV-2 infection of epithelial HEC-1 cells...
  2. doi request reprint Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV
    Joel Gozlan
    Service de Bacteriologie Virologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France
    J Hepatol 50:432-4. 2009
    ..An unexpected and extensive HDV replication was observed in this patient after HBs Ag had cleared from the serum, which was followed by a stable halt in HDV replication. Implications of this unusual observation will be discussed...
  3. pmc Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients
    Karine Lacombe
    INSERM UMR S707, Paris, France
    Antivir Ther 13:705-13. 2008
    ..Characteristics and factors influencing viral decay under tenofovir (TDF) and adefovir (ADV) need to be determined in HIV-HBV-coinfected patients...
  4. doi request reprint High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients
    Karine Lacombe
    INSERM UMR S707, Paris, France
    Hepatology 58:912-22. 2013
    ..88; 95% CI, 0.79-0.98). No major liver-related complications (e.g., fulminant hepatitis, decompensated liver, and hepatocellular carcinoma) were observed in patients with incident mutations...
  5. ncbi request reprint Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV
    Karine Lacombe
    INSERM U707, Paris, France
    AIDS 20:419-27. 2006
    ..Little is know about the determinants of liver fibrosis progression and genomic variability in hepatitis B virus (HBV) in HIV/HBV-coinfected patients...
  6. doi request reprint Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients
    Sarah Maylin
    Laboratoire de Virologie, Hopital Saint Louis, AP HP, Paris, France
    AIDS 26:939-49. 2012
    ..Although their quantification is useful for other antivirals, such has not been the case with tenofovir disoproxil fumarate (TDF), particularly in HIV infection...
  7. pmc Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region
    Julie Bottero
    INSERM UMR S707, Paris, France Université Pierre et Marie Curie, Paris, France Service de Maladies Infectieuses, Hopital St Antoine, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    PLoS ONE 9:e92266. 2014
    ..We aimed to evaluate whether (i) previous HBV-testing, (ii) physicians decision to screen, and (iii) CDC's recommendations identified infected individuals and which risk-factor groups needing testing...
  8. doi request reprint Drug-resistant and immune-escape HBV mutants in HIV-infected hosts
    Karine Lacombe
    INSERM, UMR S707, Paris, France
    Antivir Ther 15:493-7. 2010
    ..For patients coinfected with HIV, hepatitis B treatment options that aim to reduce the risk of HBV mutations from emerging must be seriously considered, not only from clinical but also public health perspectives...
  9. pmc A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes
    Claire Gaillard
    Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie, Universite Paris Descartes, INSERM, Paris, France
    PLoS ONE 3:e2855. 2008
    ..A prerequisite for such studies is the ability to detect HMGB1 in blood or other biological fluids and to accurately measure its concentration...
  10. doi request reprint Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells
    Nadine Nasreddine
    INSERM Unité 743, Centre de Recherche des Cordeliers, Paris F 75006, France
    J Immunol 186:5687-95. 2011
    ..Taken together, our results suggest that AGEs can play an inhibiting role in HIV-1 infection in patients who accumulate circulating AGEs, including patients treated with protease inhibitors that developed diabetes...
  11. ncbi request reprint Immediate-early antigen expression and modulation of apoptosis after in vitro infection of polymorphonuclear leukocytes by human cytomegalovirus
    Corinne Saez-Lopez
    Laboratoire de Bacteriologie virologie, Hopital Saint Antoine, 184, rue du Faubourg Saint Antoine, 75012 Paris, France
    Microbes Infect 7:1139-49. 2005
    ..These data suggest that PMNL play a key role in virus dissemination in vivo, through their interactions with infected endothelial cells...
  12. pmc Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter
    Sylvain Thierry
    UMR 7079, Universite Pierre et Marie Curie, 7 quai Saint Bernard, 75005 Paris, France
    J Virol 78:12198-206. 2004
    ..NF-kappaB and/or c-Jun binding to the LTR in G(2)-arrested cells appears to be required for CBP recruitment as well as for nuc-1 remodeling and viral reactivation...
  13. ncbi request reprint Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus
    Karine Lacombe
    INSERM, UMR S707, Paris, F 75012, France
    AIDS 21:2546-9. 2007
    ..02, 95% CI = 1.03-97.42 for HBV-HCV-HDV, compared to OR = 1.76, 95% CI = 0.50-6.17 for HBV alone]. Co-treatment of other multiple viral hepatitis infections should also be taken into consideration, especially in the case of chronic HDV...
  14. ncbi request reprint High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
    Sylvain Thierry
    UMR 7079, Universite Pierre et Marie Curie, Paris, France
    AIDS 21:283-92. 2007
    ..We focused on HMGB1, an abundant component of the chromatin that is released from necrotic cells and can act as a pro-inflammatory mediator...
  15. doi request reprint The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration
    Florence Berthelot
    Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie, UMR S 872 et Université Paris Descartes, UMR S 872, INSERM, Paris, France
    J Innate Immun 4:41-58. 2012
    ..The A box component could potentially serve to inhibit inappropriate PMN recruitment during chronic inflammatory disorders associated with excessive HMGB1 release...
  16. doi request reprint Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France
    Julie Bottero
    INSERM UMR S707, Paris, France
    J Hepatol 58:473-8. 2013
    ..The aim of this study was to evaluate the effectiveness of such tests for HBsAg and anti-HBsAb detection among individuals visiting a variety of healthcare centers located in a low HBV-prevalent area...
  17. pmc Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study
    Vincent Thibault
    Pitie Salpetriere, Paris, France
    Virol J 10:87. 2013
    ....
  18. doi request reprint Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus
    Anders Boyd
    aINSERM, UMR_S1136, Institut Pierre Louis d Epidémiologie et de Santé Publique bLaboratoire de Virologie, Hopital Saint Antoine, AP HP cUPMC UMRS CR7, INSERM U1135 CIMI, Paris dCentre de Recherche sur le Cancer de Lyon, Equipes 15 et 16, INSERM, Unité 1052, CNRS, UMR 5286 eService des Maladies Infectieuses et Tropicales, Hopital de la Croix Rousse, Hospices Civils de Lyon, Lyon fService des Maladies Infectieuses et Tropicales, Hopital Saint Louis, APHP gDepartment of Infectious and Tropical Diseases, Saint Antoine Hospital, AP HP, Paris hHepatology Unit, Hospices Civils de Lyon iUniversité de Lyon, Lyon jSorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d Epidémiologie et de Santé Publique, Paris, France
    AIDS 29:1963-73. 2015
    ....
  19. doi request reprint Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient
    Karine Cury
    Service des Maladies Infectieuses et Tropicales, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, Paris, France
    Sex Transm Dis 37:126-8. 2010
    ..Treatment with valacyclovir, cidofovir, and thalidomide failed and surgical excision was required...
  20. ncbi request reprint Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate
    Karine Lacombe
    INSERM U707, Universite Pierre et Marie Curie, 27 rue de Chaligny, 75571 Paris Cedex 12, France
    AIDS 19:907-15. 2005
    ..The long-term impact of tenofovir disoproxil fumarate (TDF) on hepatitis B virus (HBV) replication has not yet been studied in HIV-HBV-co-infected patients...